A technique for removal of the Urolume endourethral wallstent prosthesis

Anjum, Misbah; Palmer, John H.

doi:10.1111/j.1464-410x.1995.tb07798.x

Cited by 11 publications

(8 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Temporary stents are generally removed easily, rapidly and atraumatically [19, 20, 22, 25, 26]. In contrast, permanent stents induce epithelialization, complete in 70% of cases after 6–12 months [24, 27, 28, 29, 30], which usually makes them more difficult to remove [29], despite the various techniques described [31, 32]. However, the absence of epithelialization of temporary stents means that, compared to permanent stents, they have a greater tendency to migration and encrustation phenomena, which represent the two major complications of temporary stents [5, 14, 33, 34, 35].…”

Section: Discussionmentioning

confidence: 99%

A New Prostatic Stent for the Treatment of Benign Prostatic Hyperplasia in High–Risk Patients

Traxer¹,

Anidjar²,

Gaudez³

et al. 2000

European Urology

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

A New Prostatic Stent for the Treatment of Benign Prostatic Hyperplasia in High–Risk Patients

Traxer¹,

Anidjar²,

Gaudez³

et al. 2000

European Urology

View full text Add to dashboard Cite

“…The long term results of these stents were poor. Encrustation and migration was seen and hence resulted in its removal under general anaesthesia [4]. Non-epithelializing stents (Prostakath, Engineers and Doctors A/S, Copenhagen, Denmark) are inert material and avoid epithelial reaction.…”

Section: Introductionmentioning

confidence: 99%

Thermo-expandable Intra-prostatic Stent in the Treatment of Acute Urinary Retention in Elderly Patients with Significant Co-morbidities

et al. 2005

View full text Add to dashboard Cite

We assess the use of thermo-expandable intra-prostatic stent (Memokath, Engineers and Doctors A/S, Denmark) for the treatment of acute urinary retention (AUR) in men with significant co-morbidities for transurethral resection of prostate (TURP). We evaluate the pre- and post-operative complications, duration of stents in-situ and patients quality of life after the stent insertion. Patients with significant co-morbidities presenting with AUR were selected, who were unfit for TURP. The co-morbidities included ischaemic heart disease, congestive heart failure, and chronic obstructive pulmonary disease. The exclusion criteria were bladder tumour and atonic bladder. The Memokath stents were inserted using a flexible cystoscope under local anaesthesia. The patients were followed up at 3 and 6 months after the procedure and the ones who remained alive were asked to complete self-administered questionnaires and IPSS scores. Fifteen men with acute urinary retention were recruited for stent insertion with the mean age of 87 years. No peri-operative complications were recorded. Three patients died after the insertion with functional Memokath in-situ. Nine patients had good functioning stents post-operatively, and remain catheter free up to 30 months after the procedure. The mean duration of stent life was 18 months. Three long-term complications were detected, including stent migration and prostate overgrowth. The Memokath is a good option for frail elderly patients presenting with AUR. The procedure is safe and has minimal long term complications. The stent also provides a sustained good quality of life for patients and avoids the necessity of long term catheterisation.

show abstract

“…[10–12] Interestingly, proximal stents implanted for BPH and DSD were more likely to require removal in comparison to stents placed for bulbous urethral strictures. [56] Stent misplacement and stent migration were among the main causes of stent failure within proximal urethra.…”

Section: Discussionmentioning

confidence: 99%

“…[6101213] Most common complications included bleeding and urethral injury. [5611] These cases are especially challenging due to the surrounding fibrosis and hyperplastic tissue growth.…”

Section: Discussionmentioning

confidence: 99%

Endoscopic removal of a proximal urethral stent using a holmium laser: Case report and literature review

Botelho¹,

Thomas²,

Miocinovic³

et al. 2012

Urol Ann

View full text Add to dashboard Cite

Urethral stents were initially developed for the management of urethral strictures and obstructive voiding disorders in select patients. Urethral stent complications are common and may require stent explantation, which is often quite challenging. We present our experience with endoscopic removal of an encrusted UroLume proximal urethral stent in a 72-year-old male using a holmium laser. The literature on various management options and outcomes for urethral stent removal is reviewed. Endoscopic removal of proximal urethral stents is feasible and safe and should be considered as the primary treatment option in patients requiring stent extraction.

show abstract

A technique for removal of the Urolume endourethral wallstent prosthesis

Cited by 11 publications

References 2 publications

A New Prostatic Stent for the Treatment of Benign Prostatic Hyperplasia in High–Risk Patients

A New Prostatic Stent for the Treatment of Benign Prostatic Hyperplasia in High–Risk Patients

Thermo-expandable Intra-prostatic Stent in the Treatment of Acute Urinary Retention in Elderly Patients with Significant Co-morbidities

Endoscopic removal of a proximal urethral stent using a holmium laser: Case report and literature review

Contact Info

Product

Resources

About

A technique for removal of the Urolume endourethral wallstent prosthesis

Cited by 11 publications

References 2 publications

A New Prostatic Stent for the Treatment of Benign Prostatic Hyperplasia in High&ndash;Risk Patients

A New Prostatic Stent for the Treatment of Benign Prostatic Hyperplasia in High&ndash;Risk Patients

Thermo-expandable Intra-prostatic Stent in the Treatment of Acute Urinary Retention in Elderly Patients with Significant Co-morbidities

Endoscopic removal of a proximal urethral stent using a holmium laser: Case report and literature review

Contact Info

Product

Resources

About

A New Prostatic Stent for the Treatment of Benign Prostatic Hyperplasia in High–Risk Patients

A New Prostatic Stent for the Treatment of Benign Prostatic Hyperplasia in High–Risk Patients